Article Type
Article
Changed
Thu, 12/15/2022 - 15:09
Display Headline
CLEOPATRA Study and MBC

Article PDF
029030042.pdf
Author and Disclosure Information

Issue
Federal Practitioner - 29(3)
Publications
AVAHO
Federal Practitioner
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Oncology
Page Number
42
Legacy Keywords
trastuzumab, anti-human epidermal growth factor receptor 2, metastatic breast cancer, HER2, CLEOPATRA Study, pertuzumabtrastuzumab, anti-human epidermal growth factor receptor 2, metastatic breast cancer, HER2, CLEOPATRA Study, pertuzumab
Sections
Pharmacology
Clinical Topics & News
Author and Disclosure Information

Author and Disclosure Information

Article PDF
029030042.pdf
Article PDF
029030042.pdf

Issue
Federal Practitioner - 29(3)
Issue
Federal Practitioner - 29(3)
Page Number
42
Page Number
42
Publications
AVAHO
Federal Practitioner
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Publications
AVAHO
Federal Practitioner
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Oncology
Article Type
Article
Display Headline
CLEOPATRA Study and MBC
Display Headline
CLEOPATRA Study and MBC
Legacy Keywords
trastuzumab, anti-human epidermal growth factor receptor 2, metastatic breast cancer, HER2, CLEOPATRA Study, pertuzumabtrastuzumab, anti-human epidermal growth factor receptor 2, metastatic breast cancer, HER2, CLEOPATRA Study, pertuzumab
Legacy Keywords
trastuzumab, anti-human epidermal growth factor receptor 2, metastatic breast cancer, HER2, CLEOPATRA Study, pertuzumabtrastuzumab, anti-human epidermal growth factor receptor 2, metastatic breast cancer, HER2, CLEOPATRA Study, pertuzumab
Sections
Pharmacology
Clinical Topics & News
Article Source

PURLs Copyright

Inside the Article

Article PDF Media